# Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer

> **NCT02635503** · PHASE3 · UNKNOWN · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 366 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **PROCEDURE:** transrectal specimen extraction
- **PROCEDURE:** Conventional laparoscopic surgery

## Key facts

- **NCT ID:** NCT02635503
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2020-12
- **Final completion:** 2025-12
- **Target enrollment:** 366 (ESTIMATED)
- **Last updated:** 2016-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02635503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02635503, "Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02635503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*